Orthofix Medical Inc. Federal Income Tax Expense (Benefit), Continuing Operations
Orthofix Medical Inc. (OFIX) reported Federal Income Tax Expense (Benefit), Continuing Operations of $982.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2025-02-25
- Orthofix Medical Inc. federal income tax expense (benefit), continuing operations for fiscal 2024 was $982.00K, a 16.57% decline from fiscal 2023.
- Orthofix Medical Inc. federal income tax expense (benefit), continuing operations for fiscal 2023 was $1.18M, a 3.37% decline from fiscal 2022.
- Orthofix Medical Inc. federal income tax expense (benefit), continuing operations for fiscal 2022 was $1.22M, a 94.86% decline from fiscal 2021.
- Orthofix Medical Inc. federal income tax expense (benefit), continuing operations for fiscal 2021 was $23.68M.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month | Federal Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|
| 2024-12-31 | $982.00K 10-K · filed 2025-02-25 | |
| 2023-12-31 | $1.18M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $1.22M 10-K · filed 2025-02-25 | |
| 2021-12-31 | $23.68M 10-K · filed 2024-03-05 | |
| 2020-12-31 | -$15.08M 10-K · filed 2023-03-06 | |
| 2019-12-31 | $97.00K 10-K · filed 2022-02-25 | |
| 2018-12-31 | $6.05M 10-K · filed 2021-02-26 | |
| 2017-12-31 | $23.84M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $9.85M 10-K · filed 2019-02-25 | |
| 2015-12-31 | $5.65M 10-K · filed 2018-02-26 | |
| 2014-12-31 | $7.89M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $6.48M 10-K · filed 2016-02-29 | $8.63M 10-K · filed 2014-03-31 |
| 2012-12-31 | $19.66M 10-K · filed 2015-04-29 | $22.65M 10-K · filed 2013-03-01 |
| 2011-12-31 | $13.03M 10-K/A · filed 2015-03-31 | $16.87M 10-K · filed 2013-03-01 |
| 2010-12-31 | $21.62M 10-K/A · filed 2014-03-24 | $19.70M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |